In patients older than 40 years, the type 2 diabetes drug class showed increased benefits over DPP-4 inhibitors at reducing ...
Among patients with type 2 diabetes, no differences were found with biguanides vs DPP-4 inhibitors in major cardiac or cerebrovascular events, diabetic complications, or death. Biguanides vs ...
Medpage Today on MSN4d
GLP-1 Drugs in MASLD Tied to Lower Risk of Cirrhosis, DeathGLP-1 receptor agonist use was associated with a reduced risk of progressing to cirrhosis and related complications in ...
Su Yu-cheng (right)shares his experience of serving as the flag bearer for the Chinese Kendo team during the opening ceremony ...
It seems like a day doesn’t go by without another positive finding for the glucagon-like peptide 1 (GLP-1) receptoragonist ...
HealthDay on MSN3d
GLP-1 RA Use Linked to Reduced Cirrhosis Risk in MASLD, DiabetesFor patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes, glucagon-like peptide 1 ...
Chinese experts have vehemently slammed the recent false claim by the Democratic Progressive Party (DPP) authorities that the ...
Italy intends to restore its lapsed long-range anti-submarine warfare (ASW) capability through the acquisition of two new ...
PsyPost on MSN18h
Research shows diabetes drug could reduce dementia risk. Here’s how the two diseases may be linkedA Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback